Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

UK monitoring 'subvariant' of coronavirus Delta strain: Govt

The government on Tuesday (October 19) said it was monitoring a subvariant of the Delta strain of the coronavirus, which has been seen in a growing number of cases.

Prime minister Boris Johnson's spokesman said the government was keeping a "close eye" on the AY.4.2 variant but said there was no evidence it spreads more easily.


"As you would expect, we are monitoring it closely and won't hesitate to take action if necessary," he told reporters.

Overall infection rates in Britain remain stubbornly high, despite high rates of vaccination, and on Monday nearly 50,000 new cases of Covid-19 were recorded.

Some scientists have suggested that measures to mitigate close-contact transmission, such as mask-wearing indoors, could be needed to prevent cases spiralling further.

Coronavirus restrictions were lifted across the country in July after three national lockdowns.

The rise has been attributed to high numbers of infections among schoolchildren, and prompted calls for a more wide-ranging booster jab programme to combat waning immunity.

Downing Street has acknowledged the rising numbers of positive tests, hospital admissions and deaths, but pointed to fluctuations in all three rates in recent months.

Francois Balloux, professor of computational systems biology at University College London, said AY.4.2 has two spike mutations found in other coronavirus variants and was first sequenced in April 2020.

The subvariant was "rare" outside Britain and there had been only three cases detected so far in the United States, he added.

"As AY.4.2 is still at fairly low frequency, a 10 percent increase in its transmissibility could have caused only a small number of additional cases.

"As such it hasn't been driving the recent increase in case numbers in the UK."

Bayroux, director of the UCL Genetics Institute, added: "This is not a situation comparable to the emergence of Alpha and Delta that were far more transmissible (50 per cent or more) than any strain in circulation at the time.

"Here we are dealing with a potential small increase in transmissibility that would not have a comparable impact on the pandemic."

More For You

Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less
Pharma industry group unhappy with NHS drug pricing offer

The ABPI warned that £2 billion of potential investment could be under risk

Pic credit: istock

Pharma industry group unhappy with NHS drug pricing offer

The Association of the British Pharmaceutical Industry (ABPI) has rejected the UK government’s offer to cut the cost of NHS drugs pricing scheme as it felt it was inadequate.

The industry group warned that £2 billion of potential investment could be under risk and wanted prime minister Keir Starmer to intervene, The Times reports.

Keep ReadingShow less
Day Lewis celebrates 50 years of delivering care to communities

The Patel family at the unveiling of the commemorative plaque ceremony

Day Lewis celebrates 50 years of delivering care to communities

Day Lewis honoured "the people, purpose and partnerships" as it celebrated 50 years of service by unveiling a commemorative plaque at the company’s support office in Croydon.

As one of the UK’s largest independent pharmacy chains, Day Lewis has delivered trusted care to communities across the country since it was founded in 1975, by brothers Kirit and JC Patel, who was on hand to unveil the plaque.

Keep ReadingShow less
CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

Pic credit: iStock

Pharmacy owners asked to share views on new contract and its financial implications

Pharmacy owners can share their thoughts on service developments and their financial security before the upcoming Community Pharmacy England (CPE) committee meeting to be held on June 25 and 26.

The new Community Pharmacy Contractual Framework (CPCF) was completed in March with the various service and regulatory changes still in progress.

Keep ReadingShow less
Cancer treatment impact

There have been supply issues with Creon since the summer of 2024

Pic credit: iStock

Cancer patients struggle amid digestive drug shortage

Pharmacists in the Channel Islands have revealed that there is a shortage of a drug used to support digestion in cancer patients.

Creon is a pancreatic enzyme replacement therapy (PERT), which helps people living with conditions such as cystic fibrosis, pancreatitis, and pancreatic cancer to digest food.

Keep ReadingShow less